ReviewHuman vaccines & immunotherapeutics2022

Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma.

Virginia Ferraresi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.